Potentandselectiveinhibitorofhumanvascularendothelialgrowthfactorreceptor2(VEGFR-2/KDR)activity.SelectivelyinhibitsVEGFR-2(IC50=2nM)overVEGFR-1andarangeofotherreceptortyrosinekinasessuchasPDGFRβ,FGFR1,EGFRanderbB2(IC50>50μM).InhibitsVEGF-A-inducedendothelialcellproliferationinvitro(IC50=8nM).
SoldwiththepermissionofAstraZenecaUKLtd.
ZM323881hydrochlorideisalsoofferedaspartoftheTocriscreenPlusandTocriscreenKinaseInhibitorToolboxI.FindoutmoreaboutcompoundlibrariesavailablefromTocris.
Thetechnicaldataprovidedaboveisforguidanceonly.ForbatchspecificdatarefertotheCertificateofAnalysis.
AllTocrisproductsareintendedforlaboratoryresearchuseonly.
Thefollowingdataisbasedontheproductmolecularweight411.86.Batchspecificmolecularweightsmayvaryfrombatchtobatchduetosolventofhydration,whichwillaffectthesolventvolumesrequiredtopreparestocksolutions.